ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Return on equity 2019–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27.2%FY2025 · since FY2019: -12.0% → -27.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -27.2% | +51.5 pp |
| FY2024 | -78.7% | -5.6 pp |
| FY2023 | -73.0% | -29.9 pp |
| FY2022 | -43.1% | -8.8 pp |
| FY2021 | -34.3% | -14.6 pp |
| FY2020 | -19.7% | -7.7 pp |
| FY2019 | -12.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ADPT financial trends
ADPT RevenueADPT Net incomeADPT Net marginADPT Gross profitADPT Gross marginADPT Operating incomeADPT Operating marginADPT Operating cash flowADPT Free cash flowADPT Capital expendituresADPT Stock buybacksADPT Dividends paidADPT Total assetsADPT Total liabilitiesADPT Shareholders’ equityADPT overview →